Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Genetic etiology of clonal hematopoiesis of indeterminate potential (CHIP) and its impact on cardiovascular diseases

FY 2022-23

Summary
Clonal hematopoiesis of indeterminate potential (CHIP) is a condition that increases the amount of blood cells in the body in a manner comparable to blood cancer, resulting from acquired mutations allowing them to be produced at an abnormally high rate. CHIP can develop into leukemia or other blood-related cancers, but has also been observed in healthy individuals, hence the term “indeterminate potential”. CHIP affects 3-6% of the general population, and up to 20% of individuals aged >70 years, yet has only recently begun to be studied. In particular, the importance of its relation to most cardiovascular diseases remains to be established. As such, this project aims to assess the impact of CHIP on cardiovascular diseases — primarily on aortic stenosis, “most common valvular heart disease” and “third most common cardiovascular disease in the Western world” — using high-quality data from the UK Biobank. One of the largest genetic datasets, UK Biobank represents an unprecedented opportunity to examine the genetic etiology of cardiovascular diseases. Due to CHIP’s variable and delayed consequences, it is challenging to diagnose in patients. This challenge will be addressed by distinguishing inherited genetic variants from acquired ones via modern approaches. Analysis will initially be conducted on individuals of European ancestry, then extended to other ancestries available in UK Biobank. It will also examine Quebec datasets, to contribute specific knowledge of the prevalence and effect of CHIP in this province with unique genetic characteristics. By contributing to cardiovascular knowledge in diverse ancestries, this project ultimately has the potential to contribute to precision diagnostics of cardiovascular conditions and to the development of novel therapeutics.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485912
Name
MacKenzie Elby
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Genetic etiology of clonal hematopoiesis of indeterminate potential (CHIP) and its impact on cardiovascular diseases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aortic Stenosis; Bioinformatics; Cardiovascular Diseases; Clonal Hematopoiesis Of Indeterminate Potential; Exome Sequencing; Genetic Epidemiology; Quebec Cohorts; Somatic Variants
Abstract
Clonal hematopoiesis of indeterminate potential (CHIP) is a condition that increases the amount of blood cells in the body in a manner comparable to blood cancer, resulting from acquired mutations allowing them to be produced at an abnormally high rate. CHIP can develop into leukemia or other blood-related cancers, but has also been observed in healthy individuals, hence the term “indeterminate potential”. CHIP affects 3-6% of the general population, and up to 20% of individuals aged >70 years, yet has only recently begun to be studied. In particular, the importance of its relation to most cardiovascular diseases remains to be established. As such, this project aims to assess the impact of CHIP on cardiovascular diseases — primarily on aortic stenosis, “most common valvular heart disease” and “third most common cardiovascular disease in the Western world” — using high-quality data from the UK Biobank. One of the largest genetic datasets, UK Biobank represents an unprecedented opportunity to examine the genetic etiology of cardiovascular diseases. Due to CHIP’s variable and delayed consequences, it is challenging to diagnose in patients. This challenge will be addressed by distinguishing inherited genetic variants from acquired ones via modern approaches. Analysis will initially be conducted on individuals of European ancestry, then extended to other ancestries available in UK Biobank. It will also examine Quebec datasets, to contribute specific knowledge of the prevalence and effect of CHIP in this province with unique genetic characteristics. By contributing to cardiovascular knowledge in diverse ancestries, this project ultimately has the potential to contribute to precision diagnostics of cardiovascular conditions and to the development of novel therapeutics.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
MacKenzie, Elby
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~